OH-PROCTER-&-GAMBLE
5.8.2021 20:51:08 CEST | Business Wire | Press release
As an Olympic sponsor for the past 10 years, Procter & Gamble’s (NYSE: PG) focus is on celebrating and supporting the unique journeys athletes take on the road to their Olympic dreams, including the causes they champion and the work they do to drive positive change in their communities. In the lead up to the Olympic Games Tokyo 2020, P&G was inspired by the selfless actions of Olympic and Paralympic athletes around the world who stepped up and served others. This led P&G to create the Athletes for Good Fund in partnership with the International Olympic Committee (IOC) and International Paralympic Committee (IPC). Its purpose is to honor and fuel the work of Olympic and Paralympic athletes and hopefuls who lend their time, talent, and resources to charitable causes in the areas of Community Impact, Equality & Inclusion, and Environmental Sustainability. For Tokyo 2020, Athletes for Good Fund provided more than $500,000 in grants to help fuel the efforts of the recipients’ charities of choice.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210805005996/en/
Today, during a virtual panel discussion dubbed “Champions and the Causes They Champion,” co-hosts Olympic Gold Medalist Nastia Liukin (USA, Gymnastics Legend) and Olympic Silver Medalist Gus Kenworthy (Great Britain, Freestyle Skiing) were joined by four athletes who are not only incredible competitors, but also display compassion, humanity, and goodness on and off the field of play. Through their inspiring stories, we learned how each panelist found motivation based on their personal experiences, along with their passion to get involved to create positive change within their communities. Panelists included:
- Mariah Duran* , USA, Skateboarding: Having experienced firsthand the intimidation of competing in a male-dominated sport with few female mentors, Mariah serves as a role model, mentor, and advocate for young girls in skate. Through her work with Skate Like A Girl, she encourages the next generation of girls to continue pursuing their passion.
- Alice Dearing* , Great Britain, Swimming: As the first Black woman to swim for Team Great Britain at any Olympic Games, Alice has experienced the barriers within the sport of swimming that are faced among people of color. Taking matters into her own hands, Alice is a lead ambassador for the Black Swimming Association (BSA), focusing on increasing participation and changing attitudes to attract more Black people to understand the importance of learning to swim.
- Brian Afanador* , Puerto Rico, Table Tennis: After Hurricane Maria left a devastating effect on Puerto Rico, Brian used his platform as an Olympic athlete to expand awareness to help his community. In collaboration with #Yonomequito Foundation, he has helped to rebuild homes and provide necessities, like food, fresh water, and emergency services to local families in need.
- Erica Sullivan , USA, Swimming: As an openly gay, Asian American swimmer, Erica has stepped up to advocate for intersectional equality in sport. During Tokyo 2020, she used her press conference as an opportunity to bring awareness to minority groups, including the LGBTQ+ community.
“The spirit of the Olympic Games has the power to lift us up and unite us, and these incredible athletes have all taken that spirit beyond the Olympic and Paralympic Movement, and into their communities with a goal of creating positive change,” said host Nastia Liukin. “It’s inspiring to see organizations, like P&G, continuing to celebrate athletes both on and off the field, supporting their efforts to fuel good in communities so others will be inspired to do the same.”
“For me, being an Olympian is much more than just excelling at my sport; it’s also about using my platform to help the next generation of women skaters coming up reach their potential and dream big,” Mariah Duran shared. “I would not be where I am today without the community and experiences I got at Skate Like A Girl. This organization is a prominent voice for gender equality and inclusion in skateboarding and their events, camps and after school programs help make an unreal scenario, real. I am so appreciative of P&G and Athletes for Good for supporting them.”
You can view the full panel conversation here .
*Athletes for Good Fund Grant recipient
Spotlighting Those Who Lead with Love During Tokyo 2020
Throughout Tokyo 2020, P&G took its commitment to supporting athletes a step further by donating an additional two grants to the chosen charities of athletes who used their Olympic Games platform to serve and support others in Tokyo. Along with Erica Sullivan, P&G extended a donation to Pita Taufatofua (Tonga, Taekwondo), who inspired people everywhere with his generosity towards the athlete community on the ground in Tokyo. The three-time Olympian, who has 15 years of volunteer experience in the youth mental health space, publicly recognized the immense amount of pressure that athletes are put under when competing at an elite level and invited athletes to reach out to him for counseling and advice. His call to action resulted in hundreds of exchanges with athletes, both via social media and in-person at Tokyo 2020. For his efforts to serve as a sounding board for athletes and provide an uplifting voice of support, P&G is proud to recognize that the good that Pita does, is what truly makes him great.
The Athletes for Good Fund and Tokyo 2020 athlete grant donations are helping P&G to achieve its goal of reaching 2,021 Acts of Good in 2021 to support its Lead with Love campaign.
You can learn more about P&G’s Lead with Love commitment here: https://us.pg.com/lead-with-love/ .
About P&G’s 2,021 Acts of Good in 2021
At P&G, supporting our communities, fostering equality and inclusion, and protecting the planet is embedded in how we do business. We believe we have a responsibility to help improve everyday life — through the products we create and the positive impact our brands and Company can have. Under our Lead with Love campaign, P&G and its brands have committed to 2,021 acts of good this year.
About Procter & Gamble
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit https://www.pg.com/ for the latest news and information about P&G and its brands.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210805005996/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 10:00:00 CEST | Press release
Analyses from the multinational MILOS study show that LDL-C reductions achieved with up to one year of treatment with bempedoic acid-containing therapies translate to a 17.1% relative reduction and a 4.8% absolute reduction in predicted 10-year cardiovascular risk.1 Real-world data demonstrated clinically relevant mean LDL-C reductions of at least 24.9%, regardless of patient gender or glycaemic status, after one year of follow-up.2,3 Findings presented at ESC Congress 2026 reinforce the clinical value of bempedoic acid in routine clinical practice, and demonstrate the continued investment of Daiichi Sankyo in addressing outstanding unmet needs in cardiovascular disease (CVD). Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom